A global network of non-profit organisations supporting those affected by Niemann-Pick Diseases

INPDA Spotlight on Associazione Italiana Niemann Pick Onlus

Sometimes in such a big organisation as the INPDA, our various member groups can be overshadowed, but we want...

Orphazyme presents 36-month data supporting durable response to arimoclomol during Parseghian Scientific Conference for NPC Research

INPDA Community Webinar Series: Cyclo Therapeutics – Phase 3 Trial

Join us on Wednesday June 30th at 7pm BST to hear an update direct from Cyclo Therapeutics regarding their...